We have not found any cost information for this lawyer
Janine A Carlan
About Janine
Biography
Janine is a registered U.S. patent attorney and has represented clients in bench and jury patent trials throughout the United States, and has particular expertise in Hatch-Waxman cases and International Trade Commission (ITC) Section 337 cases. She has first chair experience in numerous federal district court cases, and has been involved in patent cases covering diverse areas of technology including pharmaceuticals, medical devices, electronics, software, Internet content delivery, automotive, chemical, manufacturing, furniture and plastics processing.
Practice Areas
1
Practice Area
Litigation
100%
28 years
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in Maryland for 19 years
State: Maryland
Acquired: 2006
No misconduct found
Licensed in District of Columbia for 26 years
State: District of Columbia
Acquired: 1999
No misconduct found
Licensed in California for 27 years
State: California
Acquired: 1998
No misconduct found
Location
Arent Fox LLP
1050 Connecticut Avenue NW, Washington, DC, 20036-5339
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Janine A Carlan's Reviews
Avvo Review Score
Not Yet Reviewed
Janine A Carlan's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Honors
2010
One of the Most Powerful and Influential Women in the Region, National Diversity Council
Work Experience
2003 - Present
Partner, Arent Fox, LLP
2000 - 2003
Attorney, Shook Hardy & Bacon
1998 - 2000
Attorney, Pillsbury Madison & Sutro (Now Pillsbury Winthrop Shaw Pittman)
1995 - 1998
Regulatory Affairs Associate, FMC Corporation
1992 - 1995
R&D Facilitator, McNeil Consumer Products
1990 - 1992
Manufacturing Supervisor, Astra Zeneca
Associations
State Bar of California
Member
District of Columbia Bar
Member
Maryland State Bar Association
Member
Education
1998
Widener University School of Law
JD - Juris Doctor
1990
North Carolina State University
BS - Bachelor of Science
Speaking Engagements
2012
Litigation Section Event
Social Media: The Good, the Bad, and "My Witness Tweeted What?"
2012
IP Throughout the Drug Development Lifecycle: Opportunities and Challenges
Post-Marketing IP Protection and Enforcement
2011
Litigation and Technology and Intellectual Property Section Event
Common Interest Agreements: Dangerous Liaisons?
2010
Domestic Impact of Intellectual Property in a Global Economy
Notable Decisions from the ITC
2010
Conference on Paragraph IV Disputes
Litigation with Multiple ANDA Filers
2009
Paragraph IV On Trial
Secondary Consideration Experts: The Clinician
2009
Intellectual Property Section event
Implications of the Quanta v. LG Case
2008
Paragraph IV On Trial
Secondary Consideration Experts: The Clinician
2007
Paragraph IV Disputes
Discovery in Paragraph IV Matters: Documents, Experts and Privilege
2003
Advanced Forum on Biotech Patents
Patentability of ‘Reach-Through’ Claims: US, European and Japanese Patent Office Perspectives
Publications
2005
Pharma & Bio Ingredients
Bioshield II: The proposed legislation includes controversial provisions for pharmaceutical companies
2005
Pharma & Bio Ingredients
Vioxx: A Painful Decision
2005
Pharma & Bio Ingredients
Two Key Decisions: The Merck and Purdue Cases Could Impact the Work of Every Pharmaceutical Researcher
2005
Pharma & Bio Ingredients
Authorized Generics, Despite a Flurry of Activity, Controversy Continues to Surround the Category
2005
Pharma & Bio Ingredients
IP Protection (in India and China) Intellectual Property Rights and Enforcement has been Troublesome for Decades, but Recent Dramatic Changes have Occurred
2004
FDLI Update
New Medicare Law Brings New Considerations for “Paragraph IV Litigation
2004
Pharma & Bio Ingredients
Hatch-Waxman, A look back after 20 years of regulation and a look ahead to pending provisions
Languages
Spanish